Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H5N5.ClH |
Molecular Weight | 171.588 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.NC1=NC=NC2=C1N=CN2
InChI
InChIKey=UQVDQSWZQXDUJB-UHFFFAOYSA-N
InChI=1S/C5H5N5.ClH/c6-4-3-5(9-1-7-3)10-2-8-4;/h1-2H,(H3,6,7,8,9,10);1H
DescriptionSources: https://www.drugbank.ca/drugs/DB00173Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/25797921 | https://www.ncbi.nlm.nih.gov/pubmed/9046330 | https://www.ncbi.nlm.nih.gov/pubmed/2165159 | https://www.ncbi.nlm.nih.gov/pubmed/27776394 | https://www.ncbi.nlm.nih.gov/pubmed/26243842
Sources: https://www.drugbank.ca/drugs/DB00173
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/25797921 | https://www.ncbi.nlm.nih.gov/pubmed/9046330 | https://www.ncbi.nlm.nih.gov/pubmed/2165159 | https://www.ncbi.nlm.nih.gov/pubmed/27776394 | https://www.ncbi.nlm.nih.gov/pubmed/26243842
Adenine is a nucleobase (a purine derivative). Its derivatives have a variety of roles in biochemistry including cellular respiration, in the form of both the energy-rich adenosine triphosphate (ATP) and the cofactors nicotinamide adenine dinucleotide (NAD) and flavin adenine dinucleotide (FAD). It also has functions in protein synthesis and as a chemical component of DNA and RNA. The shape of adenine is complementary to either thymine in DNA or uracil in RNA
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2096619 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2165159 |
85.8 µM [Ki] | ||
Target ID: CHEMBL308 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9046330 |
200.0 µM [IC50] | ||
Target ID: CHEMBL1929 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17379526 |
10.89 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | LEUKOTRAP WB SYSTEM Approved UseIndicated for collection of blood and preparation of red blood cells and plasma with pre-storage leukocyte reduction. Platelet concentrates are not intended to be made with this product. |
|||
Secondary | Unknown Approved UseUnknown |
|||
Secondary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
UAG readthrough in mammalian cells: effect of upstream and downstream stop codon contexts reveal different signals. | 2001 |
|
Ionization mechanism of oligonucleotides in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. | 2001 |
|
Mechanisms and modulation of intestinal epithelial repair. | 2001 Feb |
|
Renal interstitial adenosine metabolism during ischemia in dogs. | 2001 Feb |
|
Orexin A stimulates cortisol secretion from human adrenocortical cells through activation of the adenylate cyclase-dependent signaling cascade. | 2001 Feb |
|
RIZ, the retinoblastoma protein interacting zinc finger gene, is mutated in genetically unstable cancers of the pancreas, stomach, and colorectum. | 2001 Feb |
|
"Chemical preconditioning" by 3-nitropropionate reduces ischemia-reperfusion injury in cardiac-arrested rat lungs. | 2001 Feb 15 |
|
Crystal structure of human cyclin-dependent kinase 2 in complex with the adenine-derived inhibitor H717. | 2001 Feb 15 |
|
Cytomegalovirus infection increases the expression and activity of ecto-ATPase (CD39) and ecto-5'nucleotidase (CD73) on endothelial cells. | 2001 Feb 23 |
|
Adenine and guanine nucleotide-specific succinyl-CoA synthetases in the clonal beta-cell mitochondria: implications in the beta-cell high-energy phosphate metabolism in relation to physiological insulin secretion. | 2001 Jan |
|
Side chain-dependent binding of antitumor indoloquinoxaline derivatives to DNA: comparative spectroscopic and viscometric measurements. | 2001 Jan |
|
Molecular and biochemical characterization of a cytokinin oxidase from maize. | 2001 Jan |
|
Evolutionary optimization of metabolic pathways. Theoretical reconstruction of the stoichiometry of ATP and NADH producing systems. | 2001 Jan |
|
A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. | 2001 Jan |
|
Development of cloned embryos from adult rabbit fibroblasts: effect of activation treatment and donor cell preparation. | 2001 Jan |
|
Oxidation of pyridine nucleotides during Fas- and ceramide-induced apoptosis in Jurkat cells: correlation with changes in mitochondria, glutathione depletion, intracellular acidification and caspase 3 activation. | 2001 Jan 15 |
|
Regulation of protein degradation and protease expression by mannose in maize root tips. Pi sequestration by mannose may hinder the study of its signaling properties. | 2001 Mar |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26243842
the daily dose of adenine is 10-60 mg/day
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25797921
NIH/3T3 cells were plated at a density of 2 × 106 cells and left untreated overnight, cultural media was exchanged and experimental plates were exposed to adenine (200 -1200 mkM) for 24 hr. Cells were counted at various concentration of adenine or AICAR with a hemocytometer after diluting the sample 1:1 with 0.4% trypan blue solution (Sigma-Aldrich, St. Louis, MO, USA). Alternatively, the cell cytotoxicity of the cells was monitored with XTT assay. 50 μL of XTT reagent was added and the plates were then incubated for 4 hr at 37 °C in the dark. The absorbance at 490 nm with a reference wavelength set at 690 nm using VersaMax ELISA microplate reader
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000077959
Created by
admin on Mon Mar 31 18:57:19 GMT 2025 , Edited by admin on Mon Mar 31 18:57:19 GMT 2025
|
PRIMARY | |||
|
DBSALT002225
Created by
admin on Mon Mar 31 18:57:19 GMT 2025 , Edited by admin on Mon Mar 31 18:57:19 GMT 2025
|
PRIMARY | |||
|
SUB12739MIG
Created by
admin on Mon Mar 31 18:57:19 GMT 2025 , Edited by admin on Mon Mar 31 18:57:19 GMT 2025
|
PRIMARY | |||
|
364H11M7OD
Created by
admin on Mon Mar 31 18:57:19 GMT 2025 , Edited by admin on Mon Mar 31 18:57:19 GMT 2025
|
PRIMARY | |||
|
76219
Created by
admin on Mon Mar 31 18:57:19 GMT 2025 , Edited by admin on Mon Mar 31 18:57:19 GMT 2025
|
PRIMARY | |||
|
DTXSID10883907
Created by
admin on Mon Mar 31 18:57:19 GMT 2025 , Edited by admin on Mon Mar 31 18:57:19 GMT 2025
|
PRIMARY | |||
|
220-867-0
Created by
admin on Mon Mar 31 18:57:19 GMT 2025 , Edited by admin on Mon Mar 31 18:57:19 GMT 2025
|
PRIMARY | |||
|
2922-28-3
Created by
admin on Mon Mar 31 18:57:19 GMT 2025 , Edited by admin on Mon Mar 31 18:57:19 GMT 2025
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD